Disregard my questions - found all the answers in two ASX releases late last year confirming what I thought may be the case.
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability, page-52
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
0.000(0.00%) |
Mkt cap ! $159.7M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $1.87 | $1.87 | $6.418K | 3.431K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1600 | $1.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.88 | 2 | 2 |
View Market Depth
| Last trade - 10.15am 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.88 |
Change
0.000 ( 0.06 %) |
||||
| Open | High | Low | Volume | ||
| $1.87 | $1.88 | $1.87 | 480 | ||
| Last updated 10.25am 06/06/2024 ? | |||||
| EMV (ASX) Chart |